Sei Investments Co. lessened its position in Agilent Technologies Inc (NYSE:A) by 9.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 217,507 shares of the medical research company’s stock after selling 21,610 shares during the period. Sei Investments Co. owned 0.07% of Agilent Technologies worth $14,567,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Dupont Capital Management Corp bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $101,000. Front Row Advisors LLC bought a new stake in shares of Agilent Technologies in the 4th quarter valued at about $106,000. Steward Partners Investment Advisory LLC bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $213,000. Cannell Peter B & Co. Inc. bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $215,000. Finally, First Allied Advisory Services Inc. bought a new stake in shares of Agilent Technologies in the 3rd quarter valued at about $225,000.
A number of equities research analysts have commented on A shares. Zacks Investment Research upgraded Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price target on the stock in a research report on Tuesday, October 31st. Cowen reiterated a “hold” rating and issued a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Deutsche Bank set a $75.00 price target on Agilent Technologies and gave the company a “buy” rating in a research report on Tuesday, November 21st. Robert W. Baird reiterated a “buy” rating and issued a $76.00 price target on shares of Agilent Technologies in a research report on Thursday, January 18th. Finally, JPMorgan Chase & Co. upped their price target on Agilent Technologies to $75.00 and gave the company an “overweight” rating in a research report on Tuesday, November 21st. Five research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $70.98.
Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 14th. The medical research company reported $0.66 EPS for the quarter, beating the consensus estimate of $0.58 by $0.08. Agilent Technologies had a return on equity of 17.70% and a net margin of 4.25%. The company had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.16 billion. During the same quarter in the prior year, the company earned $0.53 EPS. research analysts forecast that Agilent Technologies Inc will post 2.67 earnings per share for the current year.
In other Agilent Technologies news, CFO Didier Hirsch sold 20,000 shares of the stock in a transaction that occurred on Monday, November 27th. The stock was sold at an average price of $69.40, for a total value of $1,388,000.00. Following the transaction, the chief financial officer now owns 204,851 shares in the company, valued at $14,216,659.40. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, insider Patrick Kaltenbach sold 5,000 shares of the stock in a transaction that occurred on Tuesday, November 28th. The stock was sold at an average price of $69.56, for a total value of $347,800.00. Following the completion of the transaction, the insider now owns 75,504 shares in the company, valued at approximately $5,252,058.24. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 154,707 shares of company stock worth $10,944,828.
COPYRIGHT VIOLATION NOTICE: “Sei Investments Co. Sells 21,610 Shares of Agilent Technologies Inc (A)” was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://stocknewstimes.com/2018/02/22/sei-investments-co-sells-21610-shares-of-agilent-technologies-inc-a.html.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.